相似文献
1
The Baboon (Papio spp.) as a model of human Ebola virus infection.
Viruses. 2012 Oct 23;4(10):2400-16. doi: 10.3390/v4102400.
2
A small nonhuman primate model for filovirus-induced disease.
Virology. 2011 Nov 25;420(2):117-24. doi: 10.1016/j.virol.2011.08.022. Epub 2011 Sep 28.
3
Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.
4
Mouse models for filovirus infections.
Viruses. 2012 Sep;4(9):1477-508. doi: 10.3390/v4091477. Epub 2012 Sep 7.
5
Ebola and Marburg virus vaccines.
Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26.
6
Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Antiviral Res. 2019 Nov;171:104592. doi: 10.1016/j.antiviral.2019.104592. Epub 2019 Aug 29.
7
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
Front Immunol. 2021 Aug 18;12:703986. doi: 10.3389/fimmu.2021.703986. eCollection 2021.
8
Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.
9
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.
10
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22.
引用本文的文献
1
Age-associated alterations in immune and inflammatory responses in captive olive baboons ().
Front Aging. 2025 Jan 6;5:1511370. doi: 10.3389/fragi.2024.1511370. eCollection 2024.
2
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.
Signal Transduct Target Ther. 2024 Sep 11;9(1):223. doi: 10.1038/s41392-024-01917-x.
3
Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.
J Infect Dis. 2023 Oct 18;228(Suppl 6):S446-S459. doi: 10.1093/infdis/jiad362.
4
Zebrafish-based platform for emerging bio-contaminants and virus inactivation research.
Sci Total Environ. 2023 May 10;872:162197. doi: 10.1016/j.scitotenv.2023.162197. Epub 2023 Feb 11.
5
Molecular Approaches for the Validation of the Baboon as a Nonhuman Primate Model for the Study of Zika Virus Infection.
Front Cell Infect Microbiol. 2022 Apr 14;12:880860. doi: 10.3389/fcimb.2022.880860. eCollection 2022.
6
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): Ebola virus disease.
EFSA J. 2017 Jul 18;15(7):e04890. doi: 10.2903/j.efsa.2017.4890. eCollection 2017 Jul.
7
Comparative Analysis of Cellular Immune Responses in Conventional and SPF Olive Baboons ().
Comp Med. 2020 Apr 1;70(2):160-169. doi: 10.30802/AALAS-CM-19-000035. Epub 2020 Feb 3.
8
Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics.
Viruses. 2020 Jan 13;12(1):92. doi: 10.3390/v12010092.
9
Optimization of culture conditions for the derivation and propagation of baboon (Papio anubis) induced pluripotent stem cells.
PLoS One. 2018 Mar 1;13(3):e0193195. doi: 10.1371/journal.pone.0193195. eCollection 2018.
10
Animal Models of Ebolavirus Infection.
Comp Med. 2017 Jun 1;67(3):253-262.
本文引用的文献
1
Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution.
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15716-21. doi: 10.1073/pnas.1211740109. Epub 2012 Aug 13.
2
Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012).
Arch Virol. 2012 Jul;157(7):1411-22. doi: 10.1007/s00705-012-1299-6. Epub 2012 Apr 6.
3
Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever.
Lancet Infect Dis. 2012 Aug;12(8):635-42. doi: 10.1016/S1473-3099(12)70018-X. Epub 2012 Mar 5.
4
Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection.
J Infect Dis. 2012 Apr 1;205(7):1147-54. doi: 10.1093/infdis/jis033. Epub 2012 Mar 1.
5
Basic clinical and laboratory features of filoviral hemorrhagic fever.
J Infect Dis. 2011 Nov;204 Suppl 3:S810-6. doi: 10.1093/infdis/jir299.
6
Is Marburg virus enzootic in Gabon?
J Infect Dis. 2011 Nov;204 Suppl 3:S800-3. doi: 10.1093/infdis/jir358.
7
Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S796-9. doi: 10.1093/infdis/jir312.
8
Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques.
J Infect Dis. 2011 Nov;204 Suppl 3:S1021-31. doi: 10.1093/infdis/jir339.
9
Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus.
J Infect Dis. 2011 Nov;204 Suppl 3:S1000-10. doi: 10.1093/infdis/jir337.
10
Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14926-31. doi: 10.1073/pnas.1112149108. Epub 2011 Aug 23.
Zotero 插件